DeepMed Research

Imperial College London

🇧🇪Belgium

Country: 🇧🇪Belgium

Ownership: Private

Established: 1907-07-08

Employees: 5K

Market Cap: -

Website: http://www.imperial.ac.uk

Clinical Trials

SurgicAl Metabolic Phenotyping Longitudinal Evaluation Study

Completed

Conditions: Trauma
Hernia
Breast Cancer
Colon Cancer
Inflammatory Bowel Disease

First Posted Date: 2011-06-22

Last Posted Date: 2015-03-25

Lead Sponsor: Imperial College London

Target Recruit Count: 50

Registration Number: NCT01378013

Locations: 🇬🇧
Department of BioSurgery and Surgical Technology, Imperial College London, London, United Kingdom

Characteristics That Identify Exacerbation Risk Following Colds in COPD Patients

Completed

Conditions: Chronic Obstructive Pulmonary Disease

First Posted Date: 2011-06-20

Last Posted Date: 2015-08-24

Lead Sponsor: Imperial College London

Target Recruit Count: 35

Registration Number: NCT01376830

Locations: 🇬🇧
Imperial College, London, United Kingdom

Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa

Phase 4

Completed

Conditions: HIV
Impaired Cognition

Interventions: Drug: standard care
Drug: novel treatment

First Posted Date: 2011-06-07

Last Posted Date: 2019-10-21

Lead Sponsor: Imperial College London

Target Recruit Count: 60

Registration Number: NCT01367236

Locations: 🇬🇧
Birmingham Heartlands Hospital:, Birmingham, United Kingdom
🇬🇧
Brighton and Sussex University Hospital NHS Trust:, Brighton, United Kingdom
🇬🇧
St. Mary's Hospital, London:, United Kingdom

and more 3 locations

Personalised Medicine for Morbid Obesity

Active, not recruiting

Conditions: Diabetes

First Posted Date: 2011-06-03

Last Posted Date: 2023-11-13

Lead Sponsor: Imperial College London

Target Recruit Count: 2000

Registration Number: NCT01365416

Locations: 🇬🇧
Imperial Weight Centre, London, United Kingdom

Effect of Broccoli Sprout on Blood Levels of Sulforaphane to Reduce Responsiveness of Immune System

Not Applicable

Completed

Conditions: Healthy Volunteers

Interventions: Dietary Supplement: Brocco-sprout homogenate
Dietary Supplement: Alfalfa sprout homogenate

First Posted Date: 2011-05-20

Last Posted Date: 2019-07-08

Lead Sponsor: Imperial College London

Target Recruit Count: 6

Registration Number: NCT01357070

Locations: 🇬🇧
Cardiovascular Medicine Research Unit, Hammersmith Hospital, London, United Kingdom

Rifaximin in Fatty Liver Disease

Phase 4

Terminated

Conditions: Nonalcoholic Fatty Liver Disease
NAFLD
Nonalcoholic Steatohepatitis

Interventions: Drug: Rifaximin

First Posted Date: 2011-05-18

Last Posted Date: 2020-10-28

Lead Sponsor: Imperial College London

Target Recruit Count: 15

Registration Number: NCT01355575

Locations: 🇬🇧
Liver Unit, St Mary's Hospital, Imperial College London, London, United Kingdom

The Effects of Glycemic Optimization Before Gastric Bypass Surgery

Not Applicable

Completed

Conditions: Type 2 Diabetes

Interventions: Biological: gastric bypass

First Posted Date: 2011-05-12

Last Posted Date: 2022-03-14

Lead Sponsor: Imperial College London

Target Recruit Count: 41

Registration Number: NCT01353118

Locations: 🇬🇧
Imperial Weight Centre, Charing Cross Hospital,, London, United Kingdom
🇬🇧
Charing Cross Hospital, London, United Kingdom

The Development of a Human Model of Respiratory Syncytial Virus Infection

Not Applicable

Completed

Conditions: Respiratory Viral Infections
Respiratory Syncytial Virus Infections

Interventions: Biological: RSV A Memphis 37

First Posted Date: 2011-05-06

Last Posted Date: 2015-06-04

Lead Sponsor: Imperial College London

Target Recruit Count: 40

Registration Number: NCT01349543

Locations: 🇬🇧
St. Mary's Hospital, Imperial College London, Norfolk Place,, London, United Kingdom

The Maraviroc Darunavir/Ritonavir Once Daily Pharmacokinetic Study

Phase 1

Completed

Conditions: HIV

Interventions: Drug: Maraviroc
Drug: Truvada
Drug: Darunavir

First Posted Date: 2011-05-05

Last Posted Date: 2019-10-31

Lead Sponsor: Imperial College London

Target Recruit Count: 13

Registration Number: NCT01348763

Locations: 🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom

CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation

Phase 1

Withdrawn

Conditions: Haematological Malignancies
Allogeneic Stem Cell Transplant
CD56+CD3- NK Cells

First Posted Date: 2011-04-18

Last Posted Date: 2015-06-08

Lead Sponsor: Imperial College London

Registration Number: NCT01336478

Locations: 🇬🇧
Hammersmith Hospital, London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy